Gadavist and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with Gadavist (gadobutrol).
Gadobutrol High Blood Pressure (Hypertension)
Major Potential Hazard, Moderate plausibility
gadolinium-based contrast agents - renal impairment
Gadolinium-based contrast agents (GBCAs) increase the risk for nephrogenic systemic fibrosis (NSF) among patients with impaired elimination of the drugs. Gadobenate ion is eliminated predominately via the kidneys. The risk for NSF appears highest among patients with chronic, severe kidney disease (GFR <30 mL/min/1.73m2), or acute kidney injury. It is recommended to avoid the use of GBCAs in these patients unless the diagnostic information is essential and not available with non-contrasted MRI or other processes. NSF may result in fatal or debilitating systemic fibrosis affecting the skin, muscle and internal organs. Consider screening patients for acute kidney injury and other conditions that may reduce renal function and for patients at risk for chronically reduced renal function (e.g., age > 60 years, hypertension or diabetes), estimate the glomerular filtration rate (GFR) through laboratory testing. For patients receiving hemodialysis, physicians may consider the prompt initiation of hemodialysis following the administration of a GBCA to enhance the contrast agent's elimination. The usefulness of hemodialysis in the prevention of NSF is unknown.
Switch to professional interaction data
Gadavist drug interactions
There are 30 drug interactions with Gadavist (gadobutrol).
Gadavist disease interactions
There are 4 disease interactions with Gadavist (gadobutrol) which include:
More about Gadavist (gadobutrol)
- Gadavist consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: magnetic resonance imaging contrast media
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Lexiscan
Lexiscan is used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging ...
Baqsimi
Baqsimi is used to treat very low blood sugar (severe hypoglycemia) in adults and children aged 1 ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Gvoke
Gvoke is used subcutaneously to treat very low blood sugar (severe hypoglycemia) in people with ...
Inulin
Inulin is used for diagnosis and investigation, dietary fiber supplementation
Regadenoson
Regadenoson is used for diagnosis and investigation, radionuclide myocardial perfusion study
Arginine
Arginine is used for diagnosis and investigation, dietary supplementation
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.